Dermapharm Holding SE

52
Hold
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A2GS5D8
EUR
38.00
1 (2.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
1,180.00
1,135.00
1,024.00
942.00
793.00
700.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,180.00
1,135.00
1,024.00
942.00
793.00
700.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
281.00
265.00
185.00
165.00
159.00
117.00
Operating Expenses
63.00
59.00
13.00
9.00
10.00
10.00
General and Administration Expenses
171.00
131.00
96.00
112.00
95.00
88.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
973.00
935.00
763.00
672.00
648.00
586.00
Operating Profit (PBDIT) excl Other Income
207.00
200.00
260.00
270.00
145.00
114.00
Other Income
24.00
18.00
10.00
20.00
3.00
4.00
Operating Profit (PBDIT)
322.00
323.00
372.00
354.00
200.00
170.00
Interest
63.00
59.00
13.00
9.00
10.00
10.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
90.00
104.00
101.00
55.00
49.00
50.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
170.00
113.00
229.00
292.00
126.00
111.00
Provision for Tax
60.00
45.00
83.00
84.00
39.00
32.00
Profit After Tax
113.00
62.00
134.00
209.00
85.00
77.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.11
1.16
2.49
3.89
1.59
1.43
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 4.00% vs 10.79% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 3.51% vs -23.21% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 6.45% vs 329.46% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 82.44% vs -53.54% in Dec 2023

Compare Profit and Loss Results of Dermapharm Holding SE
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
Operating Income
1,180.00
796.00
384.00
48.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,180.00
796.00
384.00
48.24%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
281.00
458.00
-177.00
-38.65%
Operating Expenses
63.00
11.00
52.00
472.73%
General and Administration Expenses
171.00
140.00
31.00
22.14%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
973.00
968.00
5.00
0.52%
Operating Profit (PBDIT) excl Other Income
207.00
-171.00
378.00
221.05%
Other Income
24.00
39.00
-15.00
-38.46%
Operating Profit (PBDIT)
322.00
-29.00
351.00
1,210.34%
Interest
63.00
11.00
52.00
472.73%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
90.00
101.00
-11.00
-10.89%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
170.00
-236.00
406.00
172.03%
Provision for Tax
60.00
-44.00
104.00
236.36%
Profit After Tax
113.00
-196.00
309.00
157.65%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.1134
-1.1059
3.22
291.10%
Profit And Loss - Net Sales
Net Sales 1,180.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.00% vs 10.79% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 207.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.51% vs -23.21% in Dec 2023

Profit And Loss - Interest
Interest 63.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.45% vs 329.46% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 113.79 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 82.44% vs -53.54% in Dec 2023